AVA
Atlas Venture Advisors’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-112,184
| Closed | -$735K | – | 5 |
|
|
2024
Q3 | $735K | Sell |
112,184
-60,000
| -35% | -$393K | 0.15% | 5 |
|
|
2024
Q2 | $1.25M | Sell |
172,184
-60,000
| -26% | -$435K | 0.27% | 5 |
|
|
2024
Q1 | $1.76M | Sell |
232,184
-60,000
| -21% | -$455K | 0.35% | 5 |
|
|
2023
Q4 | $1.33M | Hold |
292,184
| – | – | 0.23% | 5 |
|
|
2023
Q3 | $1.15M | Hold |
292,184
| – | – | 0.25% | 5 |
|
|
2023
Q2 | $915K | Hold |
292,184
| – | – | 0.15% | 5 |
|
|
2023
Q1 | $1.32M | Hold |
292,184
| – | – | 0.29% | 6 |
|
|
2022
Q4 | $1.21M | Hold |
292,184
| – | – | 0.42% | 7 |
|
|
2022
Q3 | $935K | Hold |
292,184
| – | – | 0.34% | 7 |
|
|
2022
Q2 | $573K | Hold |
292,184
| – | – | 0.18% | 7 |
|
|
2022
Q1 | $1.18M | Hold |
292,184
| – | – | 0.25% | 7 |
|
|
2021
Q4 | $3.15M | Hold |
292,184
| – | – | 0.44% | 6 |
|
|
2021
Q3 | $3.37M | Hold |
292,184
| – | – | 0.4% | 8 |
|
|
2021
Q2 | $2.87M | Hold |
292,184
| – | – | 0.3% | 9 |
|
|
2021
Q1 | $4.27M | Hold |
292,184
| – | – | 0.79% | 7 |
|
|
2020
Q4 | $6.26M | Hold |
292,184
| – | – | 1.4% | 6 |
|
|
2020
Q3 | $4.43M | Hold |
292,184
| – | – | 0.75% | 7 |
|
|
2020
Q2 | $3.76M | Sell |
292,184
-3,214,023
| -92% | -$41.3M | 0.96% | 7 |
|
|
2020
Q1 | $2.7M | Hold |
3,506,207
| – | – | 3.66% | 6 |
|
|
2019
Q4 | $3.89M | Hold |
3,506,207
| – | – | 5.88% | 6 |
|
|
2019
Q3 | $2.59M | Hold |
3,506,207
| – | – | 0.8% | 6 |
|
|
2019
Q2 | $4.17M | Hold |
3,506,207
| – | – | 1.73% | 5 |
|
|
2019
Q1 | $9.61M | Hold |
3,506,207
| – | – | 4.85% | 3 |
|
|
2018
Q4 | $17.4M | Buy |
+3,506,207
| New | +$17.4M | 9.16% | 3 |
|